Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-06-08

Clinical Trial Update: Study to Evaluate the Potential of Air Structuring Protein to Elicit Allergic Reactions in Mold Sensitized People [NA]

View source ↗

Summary

A completed study evaluated whether Air Structuring Protein could elicit allergic reactions in people with mold allergy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Air Structuring Protein

Snippet

Sponsor: Unilever SEAC | Conditions: Allergy to Mold | NA | Status: COMPLETED